PCVX
Vaxcyte Inc
59.00$
+0.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +18.9% | +4.9% | +12.5% | +29.5% | – | – | – | – | – | – | – | – | |
| – | – | -126.9% | – | – | – | – | – | – | – | -217.3% | – | – | |
| – | +6.9% | -9.2% | +39.0% | -11.1% | +14.3% | +10.9% | +31.1% | +8.1% | +15.3% | +29.2% | -14.4% | – | |
| – | +12.3% | +13.5% | +8.0% | +7.1% | +24.2% | +14.4% | -1.9% | +1.3% | -0.7% | +2.6% | +5.6% | – | |
| – | +74.0% | -41.8% | +33.6% | -8.5% | +15.9% | +11.5% | +22.4% | +9.6% | +15.2% | +21.7% | -10.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -232.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.